Global Prostate Cancer Chemotherapy Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Prostate Cancer Chemotherapy Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The most common chemotherapy drug for prostate cancer is docetaxel (Taxotere), which is usually given with prednisone, a steroid medicine. After starting docetaxel, many men experience the improvements in disease-related symptoms, including pain, fatigue and loss of energy.

This report studies the global Prostate Cancer Chemotherapy Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Prostate Cancer Chemotherapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prostate Cancer Chemotherapy Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Prostate Cancer Chemotherapy Drugs total production and demand, 2018-2029, (K Units)
Global Prostate Cancer Chemotherapy Drugs total production value, 2018-2029, (USD Million)
Global Prostate Cancer Chemotherapy Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prostate Cancer Chemotherapy Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Prostate Cancer Chemotherapy Drugs domestic production, consumption, key domestic manufacturers and share
Global Prostate Cancer Chemotherapy Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Prostate Cancer Chemotherapy Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prostate Cancer Chemotherapy Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Prostate Cancer Chemotherapy Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Pfizer, Roche, Novartis, AbbVie, Bristol-Myer, Sanofi, AstraZeneca and Merck, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prostate Cancer Chemotherapy Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Prostate Cancer Chemotherapy Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Prostate Cancer Chemotherapy Drugs Market, Segmentation by Type
    Abiraterone Acetate
    Apalutamide
    Bicalutamide
    Cabazitaxel
    Others

Global Prostate Cancer Chemotherapy Drugs Market, Segmentation by Application
    Hospital Pharmacy
    Retail Pharmacy
    Online Sales
    Other

Companies Profiled:
    Johnson & Johnson
    Pfizer
    Roche
    Novartis
    AbbVie
    Bristol-Myer
    Sanofi
    AstraZeneca
    Merck
    Amgen
    Bayer AG
    Ipsen Group
    Endo Pharmaceuticals
    Dendreon Corporation
    Myovant Biosciences
    Effector Therapeutics
    Mediolanum
    ESSA Pharma
    Astellas Pharma
    Janssen
    Eli Lilly and Company
    POINT Biopharma
    Hinnova Pharmaceuticals
    Sophiris Bio
    Ultimovacs
    Foresee Pharmaceuticals
    Luye Pharma Group
    Abbott
    Jiangsu HengRui Medicine

Key Questions Answered
1. How big is the global Prostate Cancer Chemotherapy Drugs market?
2. What is the demand of the global Prostate Cancer Chemotherapy Drugs market?
3. What is the year over year growth of the global Prostate Cancer Chemotherapy Drugs market?
4. What is the production and production value of the global Prostate Cancer Chemotherapy Drugs market?
5. Who are the key producers in the global Prostate Cancer Chemotherapy Drugs market?

Table of Contents

1 Supply Summary
    1.1 Prostate Cancer Chemotherapy Drugs Introduction
    1.2 World Prostate Cancer Chemotherapy Drugs Supply & Forecast
        1.2.1 World Prostate Cancer Chemotherapy Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Prostate Cancer Chemotherapy Drugs Production (2018-2029)
        1.2.3 World Prostate Cancer Chemotherapy Drugs Pricing Trends (2018-2029)
    1.3 World Prostate Cancer Chemotherapy Drugs Production by Region (Based on Production Site)
        1.3.1 World Prostate Cancer Chemotherapy Drugs Production Value by Region (2018-2029)
        1.3.2 World Prostate Cancer Chemotherapy Drugs Production by Region (2018-2029)
        1.3.3 World Prostate Cancer Chemotherapy Drugs Average Price by Region (2018-2029)
        1.3.4 North America Prostate Cancer Chemotherapy Drugs Production (2018-2029)
        1.3.5 Europe Prostate Cancer Chemotherapy Drugs Production (2018-2029)
        1.3.6 China Prostate Cancer Chemotherapy Drugs Production (2018-2029)
        1.3.7 Japan Prostate Cancer Chemotherapy Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Prostate Cancer Chemotherapy Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Prostate Cancer Chemotherapy Drugs Major Market Trends

2 Demand Summary
    2.1 World Prostate Cancer Chemotherapy Drugs Demand (2018-2029)
    2.2 World Prostate Cancer Chemotherapy Drugs Consumption by Region
        2.2.1 World Prostate Cancer Chemotherapy Drugs Consumption by Region (2018-2023)
        2.2.2 World Prostate Cancer Chemotherapy Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Prostate Cancer Chemotherapy Drugs Consumption (2018-2029)
    2.4 China Prostate Cancer Chemotherapy Drugs Consumption (2018-2029)
    2.5 Europe Prostate Cancer Chemotherapy Drugs Consumption (2018-2029)
    2.6 Japan Prostate Cancer Chemotherapy Drugs Consumption (2018-2029)
    2.7 South Korea Prostate Cancer Chemotherapy Drugs Consumption (2018-2029)
    2.8 ASEAN Prostate Cancer Chemotherapy Drugs Consumption (2018-2029)
    2.9 India Prostate Cancer Chemotherapy Drugs Consumption (2018-2029)

3 World Prostate Cancer Chemotherapy Drugs Manufacturers Competitive Analysis
    3.1 World Prostate Cancer Chemotherapy Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Prostate Cancer Chemotherapy Drugs Production by Manufacturer (2018-2023)
    3.3 World Prostate Cancer Chemotherapy Drugs Average Price by Manufacturer (2018-2023)
    3.4 Prostate Cancer Chemotherapy Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Prostate Cancer Chemotherapy Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Prostate Cancer Chemotherapy Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Prostate Cancer Chemotherapy Drugs in 2022
    3.6 Prostate Cancer Chemotherapy Drugs Market: Overall Company Footprint Analysis
        3.6.1 Prostate Cancer Chemotherapy Drugs Market: Region Footprint
        3.6.2 Prostate Cancer Chemotherapy Drugs Market: Company Product Type Footprint
        3.6.3 Prostate Cancer Chemotherapy Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Prostate Cancer Chemotherapy Drugs Production Value Comparison
        4.1.1 United States VS China: Prostate Cancer Chemotherapy Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Prostate Cancer Chemotherapy Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Prostate Cancer Chemotherapy Drugs Production Comparison
        4.2.1 United States VS China: Prostate Cancer Chemotherapy Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Prostate Cancer Chemotherapy Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Prostate Cancer Chemotherapy Drugs Consumption Comparison
        4.3.1 United States VS China: Prostate Cancer Chemotherapy Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Prostate Cancer Chemotherapy Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Prostate Cancer Chemotherapy Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Prostate Cancer Chemotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Prostate Cancer Chemotherapy Drugs Production (2018-2023)
    4.5 China Based Prostate Cancer Chemotherapy Drugs Manufacturers and Market Share
        4.5.1 China Based Prostate Cancer Chemotherapy Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Prostate Cancer Chemotherapy Drugs Production (2018-2023)
    4.6 Rest of World Based Prostate Cancer Chemotherapy Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Prostate Cancer Chemotherapy Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Prostate Cancer Chemotherapy Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Prostate Cancer Chemotherapy Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Abiraterone Acetate
        5.2.2 Apalutamide
        5.2.3 Bicalutamide
        5.2.4 Cabazitaxel
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Prostate Cancer Chemotherapy Drugs Production by Type (2018-2029)
        5.3.2 World Prostate Cancer Chemotherapy Drugs Production Value by Type (2018-2029)
        5.3.3 World Prostate Cancer Chemotherapy Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Prostate Cancer Chemotherapy Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacy
        6.2.2 Retail Pharmacy
        6.2.3 Online Sales
        6.2.4 Other
    6.3 Market Segment by Application
        6.3.1 World Prostate Cancer Chemotherapy Drugs Production by Application (2018-2029)
        6.3.2 World Prostate Cancer Chemotherapy Drugs Production Value by Application (2018-2029)
        6.3.3 World Prostate Cancer Chemotherapy Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Details
        7.1.2 Johnson & Johnson Major Business
        7.1.3 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product and Services
        7.1.4 Johnson & Johnson Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Johnson & Johnson Recent Developments/Updates
        7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Prostate Cancer Chemotherapy Drugs Product and Services
        7.2.4 Pfizer Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Roche
        7.3.1 Roche Details
        7.3.2 Roche Major Business
        7.3.3 Roche Prostate Cancer Chemotherapy Drugs Product and Services
        7.3.4 Roche Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Roche Recent Developments/Updates
        7.3.6 Roche Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Prostate Cancer Chemotherapy Drugs Product and Services
        7.4.4 Novartis Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 AbbVie
        7.5.1 AbbVie Details
        7.5.2 AbbVie Major Business
        7.5.3 AbbVie Prostate Cancer Chemotherapy Drugs Product and Services
        7.5.4 AbbVie Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 AbbVie Recent Developments/Updates
        7.5.6 AbbVie Competitive Strengths & Weaknesses
    7.6 Bristol-Myer
        7.6.1 Bristol-Myer Details
        7.6.2 Bristol-Myer Major Business
        7.6.3 Bristol-Myer Prostate Cancer Chemotherapy Drugs Product and Services
        7.6.4 Bristol-Myer Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Bristol-Myer Recent Developments/Updates
        7.6.6 Bristol-Myer Competitive Strengths & Weaknesses
    7.7 Sanofi
        7.7.1 Sanofi Details
        7.7.2 Sanofi Major Business
        7.7.3 Sanofi Prostate Cancer Chemotherapy Drugs Product and Services
        7.7.4 Sanofi Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Sanofi Recent Developments/Updates
        7.7.6 Sanofi Competitive Strengths & Weaknesses
    7.8 AstraZeneca
        7.8.1 AstraZeneca Details
        7.8.2 AstraZeneca Major Business
        7.8.3 AstraZeneca Prostate Cancer Chemotherapy Drugs Product and Services
        7.8.4 AstraZeneca Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 AstraZeneca Recent Developments/Updates
        7.8.6 AstraZeneca Competitive Strengths & Weaknesses
    7.9 Merck
        7.9.1 Merck Details
        7.9.2 Merck Major Business
        7.9.3 Merck Prostate Cancer Chemotherapy Drugs Product and Services
        7.9.4 Merck Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Merck Recent Developments/Updates
        7.9.6 Merck Competitive Strengths & Weaknesses
    7.10 Amgen
        7.10.1 Amgen Details
        7.10.2 Amgen Major Business
        7.10.3 Amgen Prostate Cancer Chemotherapy Drugs Product and Services
        7.10.4 Amgen Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Amgen Recent Developments/Updates
        7.10.6 Amgen Competitive Strengths & Weaknesses
    7.11 Bayer AG
        7.11.1 Bayer AG Details
        7.11.2 Bayer AG Major Business
        7.11.3 Bayer AG Prostate Cancer Chemotherapy Drugs Product and Services
        7.11.4 Bayer AG Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Bayer AG Recent Developments/Updates
        7.11.6 Bayer AG Competitive Strengths & Weaknesses
    7.12 Ipsen Group
        7.12.1 Ipsen Group Details
        7.12.2 Ipsen Group Major Business
        7.12.3 Ipsen Group Prostate Cancer Chemotherapy Drugs Product and Services
        7.12.4 Ipsen Group Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Ipsen Group Recent Developments/Updates
        7.12.6 Ipsen Group Competitive Strengths & Weaknesses
    7.13 Endo Pharmaceuticals
        7.13.1 Endo Pharmaceuticals Details
        7.13.2 Endo Pharmaceuticals Major Business
        7.13.3 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
        7.13.4 Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Endo Pharmaceuticals Recent Developments/Updates
        7.13.6 Endo Pharmaceuticals Competitive Strengths & Weaknesses
    7.14 Dendreon Corporation
        7.14.1 Dendreon Corporation Details
        7.14.2 Dendreon Corporation Major Business
        7.14.3 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product and Services
        7.14.4 Dendreon Corporation Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Dendreon Corporation Recent Developments/Updates
        7.14.6 Dendreon Corporation Competitive Strengths & Weaknesses
    7.15 Myovant Biosciences
        7.15.1 Myovant Biosciences Details
        7.15.2 Myovant Biosciences Major Business
        7.15.3 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product and Services
        7.15.4 Myovant Biosciences Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Myovant Biosciences Recent Developments/Updates
        7.15.6 Myovant Biosciences Competitive Strengths & Weaknesses
    7.16 Effector Therapeutics
        7.16.1 Effector Therapeutics Details
        7.16.2 Effector Therapeutics Major Business
        7.16.3 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product and Services
        7.16.4 Effector Therapeutics Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Effector Therapeutics Recent Developments/Updates
        7.16.6 Effector Therapeutics Competitive Strengths & Weaknesses
    7.17 Mediolanum
        7.17.1 Mediolanum Details
        7.17.2 Mediolanum Major Business
        7.17.3 Mediolanum Prostate Cancer Chemotherapy Drugs Product and Services
        7.17.4 Mediolanum Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Mediolanum Recent Developments/Updates
        7.17.6 Mediolanum Competitive Strengths & Weaknesses
    7.18 ESSA Pharma
        7.18.1 ESSA Pharma Details
        7.18.2 ESSA Pharma Major Business
        7.18.3 ESSA Pharma Prostate Cancer Chemotherapy Drugs Product and Services
        7.18.4 ESSA Pharma Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 ESSA Pharma Recent Developments/Updates
        7.18.6 ESSA Pharma Competitive Strengths & Weaknesses
    7.19 Astellas Pharma
        7.19.1 Astellas Pharma Details
        7.19.2 Astellas Pharma Major Business
        7.19.3 Astellas Pharma Prostate Cancer Chemotherapy Drugs Product and Services
        7.19.4 Astellas Pharma Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Astellas Pharma Recent Developments/Updates
        7.19.6 Astellas Pharma Competitive Strengths & Weaknesses
    7.20 Janssen
        7.20.1 Janssen Details
        7.20.2 Janssen Major Business
        7.20.3 Janssen Prostate Cancer Chemotherapy Drugs Product and Services
        7.20.4 Janssen Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.20.5 Janssen Recent Developments/Updates
        7.20.6 Janssen Competitive Strengths & Weaknesses
    7.21 Eli Lilly and Company
        7.21.1 Eli Lilly and Company Details
        7.21.2 Eli Lilly and Company Major Business
        7.21.3 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product and Services
        7.21.4 Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.21.5 Eli Lilly and Company Recent Developments/Updates
        7.21.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.22 POINT Biopharma
        7.22.1 POINT Biopharma Details
        7.22.2 POINT Biopharma Major Business
        7.22.3 POINT Biopharma Prostate Cancer Chemotherapy Drugs Product and Services
        7.22.4 POINT Biopharma Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.22.5 POINT Biopharma Recent Developments/Updates
        7.22.6 POINT Biopharma Competitive Strengths & Weaknesses
    7.23 Hinnova Pharmaceuticals
        7.23.1 Hinnova Pharmaceuticals Details
        7.23.2 Hinnova Pharmaceuticals Major Business
        7.23.3 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
        7.23.4 Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.23.5 Hinnova Pharmaceuticals Recent Developments/Updates
        7.23.6 Hinnova Pharmaceuticals Competitive Strengths & Weaknesses
    7.24 Sophiris Bio
        7.24.1 Sophiris Bio Details
        7.24.2 Sophiris Bio Major Business
        7.24.3 Sophiris Bio Prostate Cancer Chemotherapy Drugs Product and Services
        7.24.4 Sophiris Bio Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.24.5 Sophiris Bio Recent Developments/Updates
        7.24.6 Sophiris Bio Competitive Strengths & Weaknesses
    7.25 Ultimovacs
        7.25.1 Ultimovacs Details
        7.25.2 Ultimovacs Major Business
        7.25.3 Ultimovacs Prostate Cancer Chemotherapy Drugs Product and Services
        7.25.4 Ultimovacs Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.25.5 Ultimovacs Recent Developments/Updates
        7.25.6 Ultimovacs Competitive Strengths & Weaknesses
    7.26 Foresee Pharmaceuticals
        7.26.1 Foresee Pharmaceuticals Details
        7.26.2 Foresee Pharmaceuticals Major Business
        7.26.3 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
        7.26.4 Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.26.5 Foresee Pharmaceuticals Recent Developments/Updates
        7.26.6 Foresee Pharmaceuticals Competitive Strengths & Weaknesses
    7.27 Luye Pharma Group
        7.27.1 Luye Pharma Group Details
        7.27.2 Luye Pharma Group Major Business
        7.27.3 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product and Services
        7.27.4 Luye Pharma Group Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.27.5 Luye Pharma Group Recent Developments/Updates
        7.27.6 Luye Pharma Group Competitive Strengths & Weaknesses
    7.28 Abbott
        7.28.1 Abbott Details
        7.28.2 Abbott Major Business
        7.28.3 Abbott Prostate Cancer Chemotherapy Drugs Product and Services
        7.28.4 Abbott Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.28.5 Abbott Recent Developments/Updates
        7.28.6 Abbott Competitive Strengths & Weaknesses
    7.29 Jiangsu HengRui Medicine
        7.29.1 Jiangsu HengRui Medicine Details
        7.29.2 Jiangsu HengRui Medicine Major Business
        7.29.3 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product and Services
        7.29.4 Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.29.5 Jiangsu HengRui Medicine Recent Developments/Updates
        7.29.6 Jiangsu HengRui Medicine Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Prostate Cancer Chemotherapy Drugs Industry Chain
    8.2 Prostate Cancer Chemotherapy Drugs Upstream Analysis
        8.2.1 Prostate Cancer Chemotherapy Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Prostate Cancer Chemotherapy Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Prostate Cancer Chemotherapy Drugs Production Mode
    8.6 Prostate Cancer Chemotherapy Drugs Procurement Model
    8.7 Prostate Cancer Chemotherapy Drugs Industry Sales Model and Sales Channels
        8.7.1 Prostate Cancer Chemotherapy Drugs Sales Model
        8.7.2 Prostate Cancer Chemotherapy Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Prostate Cancer Chemotherapy Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Prostate Cancer Chemotherapy Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Prostate Cancer Chemotherapy Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Prostate Cancer Chemotherapy Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Prostate Cancer Chemotherapy Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Prostate Cancer Chemotherapy Drugs Production by Region (2018-2023) & (K Units)
    Table 7. World Prostate Cancer Chemotherapy Drugs Production by Region (2024-2029) & (K Units)
    Table 8. World Prostate Cancer Chemotherapy Drugs Production Market Share by Region (2018-2023)
    Table 9. World Prostate Cancer Chemotherapy Drugs Production Market Share by Region (2024-2029)
    Table 10. World Prostate Cancer Chemotherapy Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Prostate Cancer Chemotherapy Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Prostate Cancer Chemotherapy Drugs Major Market Trends
    Table 13. World Prostate Cancer Chemotherapy Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Prostate Cancer Chemotherapy Drugs Consumption by Region (2018-2023) & (K Units)
    Table 15. World Prostate Cancer Chemotherapy Drugs Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Prostate Cancer Chemotherapy Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Prostate Cancer Chemotherapy Drugs Producers in 2022
    Table 18. World Prostate Cancer Chemotherapy Drugs Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Prostate Cancer Chemotherapy Drugs Producers in 2022
    Table 20. World Prostate Cancer Chemotherapy Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Prostate Cancer Chemotherapy Drugs Company Evaluation Quadrant
    Table 22. World Prostate Cancer Chemotherapy Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Prostate Cancer Chemotherapy Drugs Production Site of Key Manufacturer
    Table 24. Prostate Cancer Chemotherapy Drugs Market: Company Product Type Footprint
    Table 25. Prostate Cancer Chemotherapy Drugs Market: Company Product Application Footprint
    Table 26. Prostate Cancer Chemotherapy Drugs Competitive Factors
    Table 27. Prostate Cancer Chemotherapy Drugs New Entrant and Capacity Expansion Plans
    Table 28. Prostate Cancer Chemotherapy Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Prostate Cancer Chemotherapy Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Prostate Cancer Chemotherapy Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Prostate Cancer Chemotherapy Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Prostate Cancer Chemotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Prostate Cancer Chemotherapy Drugs Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Market Share (2018-2023)
    Table 37. China Based Prostate Cancer Chemotherapy Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Prostate Cancer Chemotherapy Drugs Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Prostate Cancer Chemotherapy Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Prostate Cancer Chemotherapy Drugs Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Market Share (2018-2023)
    Table 47. World Prostate Cancer Chemotherapy Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Prostate Cancer Chemotherapy Drugs Production by Type (2018-2023) & (K Units)
    Table 49. World Prostate Cancer Chemotherapy Drugs Production by Type (2024-2029) & (K Units)
    Table 50. World Prostate Cancer Chemotherapy Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Prostate Cancer Chemotherapy Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Prostate Cancer Chemotherapy Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Prostate Cancer Chemotherapy Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Prostate Cancer Chemotherapy Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Prostate Cancer Chemotherapy Drugs Production by Application (2018-2023) & (K Units)
    Table 56. World Prostate Cancer Chemotherapy Drugs Production by Application (2024-2029) & (K Units)
    Table 57. World Prostate Cancer Chemotherapy Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Prostate Cancer Chemotherapy Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Prostate Cancer Chemotherapy Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Prostate Cancer Chemotherapy Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 62. Johnson & Johnson Major Business
    Table 63. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Product and Services
    Table 64. Johnson & Johnson Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Johnson & Johnson Recent Developments/Updates
    Table 66. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 68. Pfizer Major Business
    Table 69. Pfizer Prostate Cancer Chemotherapy Drugs Product and Services
    Table 70. Pfizer Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Pfizer Recent Developments/Updates
    Table 72. Pfizer Competitive Strengths & Weaknesses
    Table 73. Roche Basic Information, Manufacturing Base and Competitors
    Table 74. Roche Major Business
    Table 75. Roche Prostate Cancer Chemotherapy Drugs Product and Services
    Table 76. Roche Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Roche Recent Developments/Updates
    Table 78. Roche Competitive Strengths & Weaknesses
    Table 79. Novartis Basic Information, Manufacturing Base and Competitors
    Table 80. Novartis Major Business
    Table 81. Novartis Prostate Cancer Chemotherapy Drugs Product and Services
    Table 82. Novartis Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Novartis Recent Developments/Updates
    Table 84. Novartis Competitive Strengths & Weaknesses
    Table 85. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 86. AbbVie Major Business
    Table 87. AbbVie Prostate Cancer Chemotherapy Drugs Product and Services
    Table 88. AbbVie Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. AbbVie Recent Developments/Updates
    Table 90. AbbVie Competitive Strengths & Weaknesses
    Table 91. Bristol-Myer Basic Information, Manufacturing Base and Competitors
    Table 92. Bristol-Myer Major Business
    Table 93. Bristol-Myer Prostate Cancer Chemotherapy Drugs Product and Services
    Table 94. Bristol-Myer Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Bristol-Myer Recent Developments/Updates
    Table 96. Bristol-Myer Competitive Strengths & Weaknesses
    Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 98. Sanofi Major Business
    Table 99. Sanofi Prostate Cancer Chemotherapy Drugs Product and Services
    Table 100. Sanofi Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Sanofi Recent Developments/Updates
    Table 102. Sanofi Competitive Strengths & Weaknesses
    Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 104. AstraZeneca Major Business
    Table 105. AstraZeneca Prostate Cancer Chemotherapy Drugs Product and Services
    Table 106. AstraZeneca Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. AstraZeneca Recent Developments/Updates
    Table 108. AstraZeneca Competitive Strengths & Weaknesses
    Table 109. Merck Basic Information, Manufacturing Base and Competitors
    Table 110. Merck Major Business
    Table 111. Merck Prostate Cancer Chemotherapy Drugs Product and Services
    Table 112. Merck Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Merck Recent Developments/Updates
    Table 114. Merck Competitive Strengths & Weaknesses
    Table 115. Amgen Basic Information, Manufacturing Base and Competitors
    Table 116. Amgen Major Business
    Table 117. Amgen Prostate Cancer Chemotherapy Drugs Product and Services
    Table 118. Amgen Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Amgen Recent Developments/Updates
    Table 120. Amgen Competitive Strengths & Weaknesses
    Table 121. Bayer AG Basic Information, Manufacturing Base and Competitors
    Table 122. Bayer AG Major Business
    Table 123. Bayer AG Prostate Cancer Chemotherapy Drugs Product and Services
    Table 124. Bayer AG Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Bayer AG Recent Developments/Updates
    Table 126. Bayer AG Competitive Strengths & Weaknesses
    Table 127. Ipsen Group Basic Information, Manufacturing Base and Competitors
    Table 128. Ipsen Group Major Business
    Table 129. Ipsen Group Prostate Cancer Chemotherapy Drugs Product and Services
    Table 130. Ipsen Group Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Ipsen Group Recent Developments/Updates
    Table 132. Ipsen Group Competitive Strengths & Weaknesses
    Table 133. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 134. Endo Pharmaceuticals Major Business
    Table 135. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
    Table 136. Endo Pharmaceuticals Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Endo Pharmaceuticals Recent Developments/Updates
    Table 138. Endo Pharmaceuticals Competitive Strengths & Weaknesses
    Table 139. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
    Table 140. Dendreon Corporation Major Business
    Table 141. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Product and Services
    Table 142. Dendreon Corporation Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Dendreon Corporation Recent Developments/Updates
    Table 144. Dendreon Corporation Competitive Strengths & Weaknesses
    Table 145. Myovant Biosciences Basic Information, Manufacturing Base and Competitors
    Table 146. Myovant Biosciences Major Business
    Table 147. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Product and Services
    Table 148. Myovant Biosciences Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Myovant Biosciences Recent Developments/Updates
    Table 150. Myovant Biosciences Competitive Strengths & Weaknesses
    Table 151. Effector Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 152. Effector Therapeutics Major Business
    Table 153. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Product and Services
    Table 154. Effector Therapeutics Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Effector Therapeutics Recent Developments/Updates
    Table 156. Effector Therapeutics Competitive Strengths & Weaknesses
    Table 157. Mediolanum Basic Information, Manufacturing Base and Competitors
    Table 158. Mediolanum Major Business
    Table 159. Mediolanum Prostate Cancer Chemotherapy Drugs Product and Services
    Table 160. Mediolanum Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Mediolanum Recent Developments/Updates
    Table 162. Mediolanum Competitive Strengths & Weaknesses
    Table 163. ESSA Pharma Basic Information, Manufacturing Base and Competitors
    Table 164. ESSA Pharma Major Business
    Table 165. ESSA Pharma Prostate Cancer Chemotherapy Drugs Product and Services
    Table 166. ESSA Pharma Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. ESSA Pharma Recent Developments/Updates
    Table 168. ESSA Pharma Competitive Strengths & Weaknesses
    Table 169. Astellas Pharma Basic Information, Manufacturing Base and Competitors
    Table 170. Astellas Pharma Major Business
    Table 171. Astellas Pharma Prostate Cancer Chemotherapy Drugs Product and Services
    Table 172. Astellas Pharma Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 173. Astellas Pharma Recent Developments/Updates
    Table 174. Astellas Pharma Competitive Strengths & Weaknesses
    Table 175. Janssen Basic Information, Manufacturing Base and Competitors
    Table 176. Janssen Major Business
    Table 177. Janssen Prostate Cancer Chemotherapy Drugs Product and Services
    Table 178. Janssen Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 179. Janssen Recent Developments/Updates
    Table 180. Janssen Competitive Strengths & Weaknesses
    Table 181. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
    Table 182. Eli Lilly and Company Major Business
    Table 183. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Product and Services
    Table 184. Eli Lilly and Company Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 185. Eli Lilly and Company Recent Developments/Updates
    Table 186. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 187. POINT Biopharma Basic Information, Manufacturing Base and Competitors
    Table 188. POINT Biopharma Major Business
    Table 189. POINT Biopharma Prostate Cancer Chemotherapy Drugs Product and Services
    Table 190. POINT Biopharma Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 191. POINT Biopharma Recent Developments/Updates
    Table 192. POINT Biopharma Competitive Strengths & Weaknesses
    Table 193. Hinnova Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 194. Hinnova Pharmaceuticals Major Business
    Table 195. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
    Table 196. Hinnova Pharmaceuticals Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 197. Hinnova Pharmaceuticals Recent Developments/Updates
    Table 198. Hinnova Pharmaceuticals Competitive Strengths & Weaknesses
    Table 199. Sophiris Bio Basic Information, Manufacturing Base and Competitors
    Table 200. Sophiris Bio Major Business
    Table 201. Sophiris Bio Prostate Cancer Chemotherapy Drugs Product and Services
    Table 202. Sophiris Bio Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 203. Sophiris Bio Recent Developments/Updates
    Table 204. Sophiris Bio Competitive Strengths & Weaknesses
    Table 205. Ultimovacs Basic Information, Manufacturing Base and Competitors
    Table 206. Ultimovacs Major Business
    Table 207. Ultimovacs Prostate Cancer Chemotherapy Drugs Product and Services
    Table 208. Ultimovacs Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 209. Ultimovacs Recent Developments/Updates
    Table 210. Ultimovacs Competitive Strengths & Weaknesses
    Table 211. Foresee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 212. Foresee Pharmaceuticals Major Business
    Table 213. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Product and Services
    Table 214. Foresee Pharmaceuticals Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 215. Foresee Pharmaceuticals Recent Developments/Updates
    Table 216. Foresee Pharmaceuticals Competitive Strengths & Weaknesses
    Table 217. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
    Table 218. Luye Pharma Group Major Business
    Table 219. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Product and Services
    Table 220. Luye Pharma Group Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 221. Luye Pharma Group Recent Developments/Updates
    Table 222. Luye Pharma Group Competitive Strengths & Weaknesses
    Table 223. Abbott Basic Information, Manufacturing Base and Competitors
    Table 224. Abbott Major Business
    Table 225. Abbott Prostate Cancer Chemotherapy Drugs Product and Services
    Table 226. Abbott Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 227. Abbott Recent Developments/Updates
    Table 228. Jiangsu HengRui Medicine Basic Information, Manufacturing Base and Competitors
    Table 229. Jiangsu HengRui MedicineMajor Business
    Table 230. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Product and Services
    Table 231. Jiangsu HengRui Medicine Prostate Cancer Chemotherapy Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 232. Global Key Players of Prostate Cancer Chemotherapy Drugs Upstream (Raw Materials)
    Table 233. Prostate Cancer Chemotherapy Drugs Typical Customers
    Table 234. Prostate Cancer Chemotherapy Drugs Typical Distributors
List of Figure
    Figure 1. Prostate Cancer Chemotherapy Drugs Picture
    Figure 2. World Prostate Cancer Chemotherapy Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Prostate Cancer Chemotherapy Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Prostate Cancer Chemotherapy Drugs Production (2018-2029) & (K Units)
    Figure 5. World Prostate Cancer Chemotherapy Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Prostate Cancer Chemotherapy Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Prostate Cancer Chemotherapy Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Prostate Cancer Chemotherapy Drugs Production (2018-2029) & (K Units)
    Figure 9. Europe Prostate Cancer Chemotherapy Drugs Production (2018-2029) & (K Units)
    Figure 10. China Prostate Cancer Chemotherapy Drugs Production (2018-2029) & (K Units)
    Figure 11. Japan Prostate Cancer Chemotherapy Drugs Production (2018-2029) & (K Units)
    Figure 12. Prostate Cancer Chemotherapy Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 15. World Prostate Cancer Chemotherapy Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 17. China Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 18. Europe Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 19. Japan Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 22. India Prostate Cancer Chemotherapy Drugs Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Prostate Cancer Chemotherapy Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Prostate Cancer Chemotherapy Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Prostate Cancer Chemotherapy Drugs Markets in 2022
    Figure 26. United States VS China: Prostate Cancer Chemotherapy Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Prostate Cancer Chemotherapy Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Prostate Cancer Chemotherapy Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Prostate Cancer Chemotherapy Drugs Production Market Share 2022
    Figure 32. World Prostate Cancer Chemotherapy Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Prostate Cancer Chemotherapy Drugs Production Value Market Share by Type in 2022
    Figure 34. Abiraterone Acetate
    Figure 35. Apalutamide
    Figure 36. Bicalutamide
    Figure 37. Cabazitaxel
    Figure 38. Others
    Figure 39. World Prostate Cancer Chemotherapy Drugs Production Market Share by Type (2018-2029)
    Figure 40. World Prostate Cancer Chemotherapy Drugs Production Value Market Share by Type (2018-2029)
    Figure 41. World Prostate Cancer Chemotherapy Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 42. World Prostate Cancer Chemotherapy Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 43. World Prostate Cancer Chemotherapy Drugs Production Value Market Share by Application in 2022
    Figure 44. Hospital Pharmacy
    Figure 45. Retail Pharmacy
    Figure 46. Online Sales
    Figure 47. Other
    Figure 48. World Prostate Cancer Chemotherapy Drugs Production Market Share by Application (2018-2029)
    Figure 49. World Prostate Cancer Chemotherapy Drugs Production Value Market Share by Application (2018-2029)
    Figure 50. World Prostate Cancer Chemotherapy Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 51. Prostate Cancer Chemotherapy Drugs Industry Chain
    Figure 52. Prostate Cancer Chemotherapy Drugs Procurement Model
    Figure 53. Prostate Cancer Chemotherapy Drugs Sales Model
    Figure 54. Prostate Cancer Chemotherapy Drugs Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Companies Mentioned

Johnson & Johnson
Pfizer
Roche
Novartis
AbbVie
Bristol-Myer
Sanofi
AstraZeneca
Merck
Amgen
Bayer AG
Ipsen Group
Endo Pharmaceuticals
Dendreon Corporation
Myovant Biosciences
Effector Therapeutics
Mediolanum
ESSA Pharma
Astellas Pharma
Janssen
Eli Lilly and Company
POINT Biopharma
Hinnova Pharmaceuticals
Sophiris Bio
Ultimovacs
Foresee Pharmaceuticals
Luye Pharma Group
Abbott
Jiangsu HengRui Medicine